Page last updated: 2024-11-04

tegafur and Leukemia, Erythroblastic, Acute

tegafur has been researched along with Leukemia, Erythroblastic, Acute in 2 studies

Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Research Excerpts

ExcerptRelevanceReference
"A 54-year-old man with colon cancer underwent hemicolectomy."1.32Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer. ( Miyazaki, M; Nakamori, Y; Shinohara, K; Taguchi, A; Tominaga, T, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsumoto, K1
Kitanaka, A1
Uemura, M1
Waki, F1
Fukumoto, T1
Ohnishi, H1
Kubota, Y1
Ishida, T1
Nakamori, Y1
Miyazaki, M1
Tominaga, T1
Taguchi, A1
Shinohara, K1

Other Studies

2 other studies available for tegafur and Leukemia, Erythroblastic, Acute

ArticleYear
S-1 induced secondary acute erythroid leukemia with a chromosome inv(12)(p13;q13).
    World journal of gastroenterology, 2011, Nov-07, Volume: 17, Issue:41

    Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Chromosome Inversion; Drug Combinatio

2011
Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer.
    International journal of clinical oncology, 2003, Volume: 8, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes,

2003